SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance

U.S. Markets open in 2 hrs 9 mins

Sanofi (SNY)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
40.35+0.18 (+0.45%)
At close: 4:02PM EST

40.32 -0.03 (-0.07%)
Pre-Market: 4:53AM EST

People also watch
NVSGSKAZNLLYNVO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close40.17
Open40.42
Bid0.00 x
Ask0.00 x
Day's Range40.23 - 40.58
52 Week Range36.81 - 44.50
Volume988,391
Avg. Volume2,203,803
Market Cap100.95B
Beta0.83
PE Ratio (TTM)23.45
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.66 (4.12%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters3 days ago

    Sanofi's M&A misses frustrate some investors in drugmaker

    PARIS/DAVOS, Switzerland (Reuters) - For the last year, Sanofi's chief executive has made clear his quest for deals to help revive the fortunes of France's biggest drugmaker. Olivier Brandicourt's failure to land two big biotech acquisitions he was chasing has led to growing impatience among some investors. In an interview at the World Economic Forum in the Swiss resort of Davos this week Brandicourt defended his track record, citing an unwillingness to overpay for pricey assets and a paucity of good opportunities.

  • MannKind Has a New Plan, but Will It Work?
    Motley Fool5 days ago

    MannKind Has a New Plan, but Will It Work?

    MannKind plans to more than double its sales force and air TV commercials plus more to increase Afrezza sales. Will this plan work?

  • Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval
    Zacks5 days ago

    Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval

    Sanofi (SNY) announced that the European Commission has granted marketing authorization to its once-daily injection, Suliqua a combination of diabetes drugs Lantus and lixisenatide for the treatment of diabetes.